trending Market Intelligence /marketintelligence/en/news-insights/trending/w_sj5cd9tnded_2awtqwlw2 content esgSubNav
In This List

HLS Therapeutics names CFO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


HLS Therapeutics names CFO

HLS Therapeutics Inc. appointed Tim Hendrickson as CFO, effective Sept. 6.

Hendrickson previously was the company's vice president of finance and administration, a position he has held since 2015.

Toronto-based HLS Therapeutics acquires and distributes in North American markets pharmaceutical products for the central nervous system and cardiovascular specialties.